ICMR studying effectiveness of Covishield, Covaxin against severe forms of Covid-19

The exercise assumes significance amid concerns that the vaccines may not be offering complete protection from hospitalisations, severe disease, and deaths,

Published: 29th May 2021 03:26 PM  |   Last Updated: 01st June 2021 07:39 PM   |  A+A-

Covishield vaccine (L) and Covaxin (R)

Covishield vaccine (L) and Covaxin (R) (Photos | EPS)

Express News Service

NEW DELHi: The Indian Council of Medical Research (ICMR) has started a crucial project to measure the real-world effectiveness of Covishield and Covaxin, authorities told The New Indian Express.

The exercise, which started earlier this week, assumes significance amid concerns that the vaccines may not be offering complete protection from hospitalisations, severe disease, and deaths, contrary to the results claimed in the clinical trials.

Many people with both doses of Covishield and Covaxin have landed up in hospitals after contracting the virus, and few have even died as per anecdotal reports but there is no concrete official data on such people so far.

There have also been concerns that these vaccines may be less effective against the B1617 variant of SARS CoV 2, the strain that has been driving the second wave of the pandemic in India.

The exercise being led by the Chennai based National Institute of Epidemiology under the ICMR is using a case control protocol of tracking about 4,000 people at 11 sites across 10 cities in India.

ALSO READ | 9,462 villages in Chhattisgarh completely 'corona-free'

Tarun Bhatnagar, scientist with the NIE who is the principal investigator for the study, told TNIE that while clinical trials give the efficacy data on whether vaccines will work, effectiveness study will gauge whether vaccines are working in real world settings in preventing serious Covid.

“This study is also crucial to determine whether the effect of vaccines is influenced by other factors such as age, prior Covid, number of doses and variants among others,” he said.

The sites where the study will be carried out include AIIMS hospitals in Delhi, Jodhpur, Rishikesh and  Bhubaneswar, Hamdard in Delhi, SMIMER, Surat, Government medical college, Nagpur, JSS medical college in Mysore, JIPMER, Puducherry and SRM medical college, Chennai.

As part of the study, the vaccination status of nearly 1,300 severe Covid-19 patients admitted in hospitals will be compared with the vaccination status of around 2,600 persons who are found Covid-19 negative in tests.

“If the vaccines are effective, the proportion of the unvaccinated should be much higher among the 1,300 than among the 2,600,” said an ICMR official “The study is expected to yield an actual number for effectiveness in percentage terms and the results are expected within the next 2-3 months.”

Incidentally, West Bengal too has planned an independent project to track vaccination status and the disease outcome of every severe Covid patient admitted in 4 hospitals in Kolkata over a 7-day period.

The plan is to analyse 428 patients, 107 each in 4 hospitals and assess whether vaccination status has any association with the worst clinical outcome or death.

ALSO WATCH | Is B.1.617 variant spreading at a frightening speed?


Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp